Aripiprazole Lauroxil (Aristada): An Extended-Release, Long-Acting Injection For the Treatment of Schizophrenia

Benzer Materyaller

• Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients with Schizophrenia
  Yazar:: Raedler, Lisa A.
  Baskı/Yayın Bilgisi: (2016)
• Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia
  Yazar:: Hard, Marjie L., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review
  Yazar:: Maini, Kunal, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia
  Yazar:: Citrome L, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-03-01)
• Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal(®) Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil
  Yazar:: Hard, Marjie L., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)